Hims & Hers Health (HIMS) Common Equity (2019 - 2025)
Hims & Hers Health (HIMS) has disclosed Common Equity for 7 consecutive years, with $540.9 million as the latest value for Q4 2025.
- Quarterly Common Equity rose 13.47% to $540.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $540.9 million through Dec 2025, up 13.47% year-over-year, with the annual reading at $540.9 million for FY2025, 13.47% up from the prior year.
- Common Equity hit $540.9 million in Q4 2025 for Hims & Hers Health, down from $581.0 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $581.0 million in Q3 2025 to a low of $292.5 million in Q1 2021.
- Historically, Common Equity has averaged $385.4 million across 5 years, with a median of $339.3 million in 2021.
- Biggest five-year swings in Common Equity: skyrocketed 347.77% in 2021 and later dropped 12.45% in 2022.
- Year by year, Common Equity stood at $334.6 million in 2021, then decreased by 6.84% to $311.7 million in 2022, then rose by 10.36% to $344.0 million in 2023, then skyrocketed by 38.57% to $476.7 million in 2024, then increased by 13.47% to $540.9 million in 2025.
- Business Quant data shows Common Equity for HIMS at $540.9 million in Q4 2025, $581.0 million in Q3 2025, and $562.7 million in Q2 2025.